Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.
M. Ryberg(University of Copenhagen), P Dombernowsky(Unknown), Benny Vittrup Jensen(Gentofte Hospital), Josie Hansen, Dorte Nielsen(Herlev Hospital), Torben Skovsgaard(Unknown)
Cited by 285
Related Papers
Effect of Obesity on Prognosis After Early-Stage Breast Cancer
|Journal of Clinical Oncology|2010|600
Serum YKL-40, A New Prognostic Biomarker in Cancer Patients?
|Cancer Epidemiology Biomarkers & Prevention|2006|364
Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors
|Cancer Treatment Reviews|2013|328
A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity
|BMC Pharmacology and Toxicology|2014|264